Il-1β-Releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from cd34+ precursors

Haematologica

Volumn 100, Issue 2, 2015, Pages e42-e45

  Vitale, Chiara ^a,b   Ambrosini, Paolo ^b   Montaldo, Elisa ^b   Ballerini, Filippo ^a,b   Moretta, Lorenzo ^c   Mingari, Maria Cristina ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

Acute myeloid leukemia; CD34+ precursors; Natural killer cell

Indexed keywords

CD161 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 8; PHARMACOLOGY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CASE CONTROL STUDY; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; DRUG THERAPY; FEMALE; FETUS BLOOD; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; INFLAMMATION; KARYOTYPE; LEUKEMIA, MYELOID, ACUTE; MALE; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; PATHOLOGY; PHENOTYPE; WESTERN BLOTTING;

ADULT; AGED; ANTIGENS, CD34; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOLOGY; DRUG EFFECTS; DRUG THERAPY; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; IMMUNOLOGY; INTERLEUKIN-1BETA; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID, ACUTE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHARMACOLOGY; PHENOTYPE;

EID: 84963944332     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.110494     Document Type: Article

References (15)

1. Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, Moretta A. Killer Ig-like receptor-mediated control of natural killer cell allore-activity in haploidentical hematopoietic stem cell transplantation. Blood. 2011;117(3):764-771.
2. Locatelli F, Pende D, Mingari MC, et al. Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells. Front Immunol. 2013;4:15.
3. Yu J, Freud AG, Caligiuri MA. Location and cellular stages of natural killer cell development. Trends Immunol. 2013;34(12):573-582.
4. Montaldo E, Vitale C, Cottalasso F, et al. Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. Blood. 2012; 119(17):3987-3996.
5. Montaldo E, Vacca P, Moretta L, Mingari MC. Development of human natural killer cells and other innate lymphoid cells. Semin Immunol. 2014;26(2):107-113.
6. Mussai F, De Santo C, Abu-Dayyeh I, et al. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenviron-ment. Blood. 2013;122(5):749-758.
7. Curti A, Trabanelli S, Salvestrini V, Baccarani M, Lemoli RM. The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood. 2009;113(11):2394-2401.
8. Ayala F, Dewar R, Kieran M, Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia. 2009;23(12):2233-2241.
9. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-899.
10. Tsimberidou AM, Estey E, Wen S, et al. The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes. Cancer. 2008;113(7):1605-1613.
11. Kornblau SM, McCue D, Singh N, Chen W, Estrov Z, Coombes KR. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia. Blood. 2010;116(20):4251-4261.
12. Costello RT, Sivori S, Marcenaro E, et al. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood. 2002;99(10):3661-3667.
13. Carlsten M, Baumann BC, Simonsson M, et al. Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome. Leukemia. 2010;24(9):1607-1616.
14. Szczepanski MJ, Szajnik M, Welsh A, Whiteside TL, Boyiadzis M. Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1. Haematologica. 2011; 96(9):1302-1309.
15. Stringaris K, Sekine T, Khoder A, et al. Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia. Haematologica. 2014; 99(5):836-847.